NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1902997695 M.D.
Verify on CMS → Munro Levitzky, M.D.
Ophthalmology Physician in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
850
Medicare Part D claims · 197 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$116.5
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Munro Levitzky, M.D. reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 850 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 850
- Part D claims, 2023
- 54%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Munro Levitzky, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Munro Levitzky, M.D. sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Munro Levitzky, M.D. writes more Part D claims than 40% of them and scores higher on MIPS quality than 15% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Munro Levitzky, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Munro Levitzky, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Munro Levitzky, M.D.?
Below national averagePrimary specialty
Ophthalmology Physician
Medicare Part D claims
850 40% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in New York
How Ophthalmology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Munro Levitzky, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Munro Levitzky, M.D. appears in the CMS NPPES registry as an Ophthalmology Physician provider holding M.D. credentials at 161 MADISON AVE, New York, NY, 10016, with a listed phone of (212) 725-5225. NPI 1902997695 was issued on 09/27/2006.
Medicare Part D records for calendar year 2023 show 850 prescription claims written by this provider, covering 197 Medicare beneficiaries and totaling roughly $214K in drug spend, split 46% brand-name and 54% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1902997695 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/27/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Munro Levitzky, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$117
Largest payer
Gilead Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Munro Levitzky, M.D.. To verify Munro Levitzky, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Munro Levitzky, M.D. - brand share 46.0%
Ophthalmology Physician average
46% brand-name claims vs 54% generic, on 850 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
850
Total Claims
$214K
Total Drug Cost
197
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,641
- Total Day Supply
- 47,162
- Brand vs Generic
- 46% brand / 54% generic
- Brand Drug Cost
- $191K
- Generic Drug Cost
- $24K
Patient Demographics
- Average Patient Age
- 81.1 years
- Avg HCC Risk Score
- 1.23
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 0, 65-74: 40, 75-84: 97, 85+: 60
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Munro Levitzky, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
184 claims
- Lumigan
Lumigan
155 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
116 claims
- Tobramycin-Dexamet… 56
Tobramycin-Dexamethasone
56 claims
- Combigan 35
Combigan
35 claims
- Timolol Maleate 32
Timolol Maleate
32 claims
- Restasis 28
Restasis
28 claims
- Prednisolone Acetate 25
Prednisolone Acetate
25 claims
| Drug | Claims |
|---|---|
| Latanoprost | 184 |
| Lumigan Bimatoprost | 155 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 116 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 56 |
| Combigan Brimonidine Tartrate/Timolol | 35 |
| Timolol Maleate | 32 |
| Restasis Cyclosporine | 28 |
| Prednisolone Acetate | 25 |
| Dorzolamide Hcl | 24 |
| Brimonidine Tartrate | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Munro Levitzky, M.D. fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Munro Levitzky, M.D.'s 850 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Levitzky.
Dr. Aliaa Abdelhakim Hamed
M.D., PH.D.
New York, NY
Dr. Majida Abdul Gaffar
M.D.
Hawthorne, NY
Dr. David H Abramson
MD
New York, NY
Dr. Frank Accardi
MD
New York, NY
Dr. Jacob Ackerman
MD
Brooklyn, NY
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Munro Levitzky, M.D.'s specialty? ▼
Munro Levitzky, M.D. specializes in Ophthalmology Physician and practices in New York, New York. Credentials: M.D..
How much does Munro Levitzky, M.D. prescribe under Medicare Part D? ▼
In 2023, Munro Levitzky, M.D. wrote 850 Medicare Part D claims totaling $214K in drug costs for 197 beneficiaries.
What is Munro Levitzky, M.D.'s Medicare quality score? ▼
Munro Levitzky, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Munro Levitzky, M.D. located? ▼
Munro Levitzky, M.D. is located at 161 MADISON AVE, New York, NY, 10016. Phone: (212) 725-5225.
What is Munro Levitzky, M.D.'s NPI number? ▼
Munro Levitzky, M.D.'s National Provider Identifier (NPI) is 1902997695, issued on 09/27/2006.
Does Munro Levitzky, M.D. prescribe more brand-name or generic drugs? ▼
Munro Levitzky, M.D.'s prescribing is 46% brand-name and 54% generic drugs by claim count, with $191K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Munro Levitzky, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Munro Levitzky, M.D.'s most frequently prescribed drugs include Latanoprost, Lumigan, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Munro Levitzky, M.D. accept Medicare? ▼
Munro Levitzky, M.D. appears in CMS Medicare data with 850 Part D claims and 197 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Munro Levitzky, M.D.'s credentials? ▼
Munro Levitzky, M.D.'s NPI is 1902997695 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.